CloseSubscribe to our newsletter What is a 708 investor?By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. RESEARCH AND NEWSEmpowering investors with access to the best research, experts and opportunities.SUBSCRIBE Search for: THIS WEEK'S NEWSIs this Australia’s next biotech success story?One of the most advanced cancer therapies on the ASX, Prescient Therapeutics’ (ASX: PTX) PTX-100 is currently in Phase 2a trials for its first targeted cancer, Cutaneous T-Cell Lymphoma (CTCL), which many clinicians see as a death sentence in the…News | 8 September 2026 Prescient Therapeutics – Live Investor Briefing – Pitt Street ResearchUncategorised | 10 September 2026Is this Australia’s next biotech success story?News | 8 September 2026Prescient Therapeutics (ASX: PTX) Webcast ReplayUncategorised | 4 September 2026More postsPrescient Therapeutics – Live Investor Briefing – Pitt Street ResearchUncategorisedIs this Australia’s next biotech success story?NewsPrescient Therapeutics (ASX: PTX) Webcast ReplayUncategorisedPrescient Therapeutics (ASX: PTX) Webcast ReplayUncategorisedAussie medtech readies ASX IPO to combat world’s second-biggest killerNewsPitt Street Research briefing on Prescient Therapeutics (ASX: PTX)UncategorisedNicolab Investment Opportunity – Live Investor BriefingUncategorisedWEBCASTS AND MEDIAView All WebcastsJoin our next webcastNEWSSee all newsRESEARCHIs this Australia’s next biotech success story?News |Aussie medtech readies ASX IPO to combat world’s second-biggest killerNews | 7 July 2026Aussie company solving military supply issues for the US, UK and UkraineNews | 25 May 2026How this ASX biotech could potentially address 22% of all cancers worldwideNews | 22 April 2026The critical mineral behind AI chips: Why existing suppliers can’t meet demandsNews | 15 April 2026Aussies in Silicon Valley Winning Business Off Databricks and SnowflakeNews | 6 April 2026See all researchSign up for our weekly newsletterSubscribe and receive the latest financial news, research and exclusive investment opportunities direct to your inbox.Subscribe
